[Study of the toxicity and pharmacological properties of the new antibiotic lienomycin].
D000315:Adrenalectomy; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000633:toxicity*; D001663:Bilirubin / Q000097:blood; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004285:Dogs; D004562:Electrocardiography; D006439:Hemodynamics / Q000187:drug effects; D007422:Intestines / Q000187:drug effects; D007668:Kidney; D007677:Kidney Function Tests; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D009400:Nephrosclerosis / Q000139:chemically induced; D009469:Neuromuscular Junction / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects; D013154:Spleen / Q000187:drug effects; D000637:Transaminases / Q000097:blood; D014662:Vasoconstrictor Agents / Q000494:pharmacology
D000903:Antibiotics, Antineoplastic; D014662:Vasoconstrictor Agents; D000637:Transaminases; D001663:Bilirubin
Issledovanie toksichnosti i farmakologicheskikh svoĭstv novogo antibiotika lienomitsina.